India has approved the Covid-19 vaccine from the US-based Moderna, allowing its imports and entry into the vaccination campaign, a senior health official announced on Tuesday.
However, the vaccine maker’s Indian partner declined comment for now on timelines and doses.
Advertisement
The apex regulatory authority for drugs and vaccines has approved an application received from Cipla, Moderna’s Indian partner, for emergency use authorisation of the vaccine, said Vinod Paul, the chair of an expert panel guiding the Centre on its Covid-19 vaccination policy.
“Our vaccine basket is now richer by this addition… this potentially opens up a clear likelihood of the vaccine being imported into India,” Paul said. “Let’s wait and see how this opportunity will be used for imports of the vaccine into the country.”
Battered by the second wave of covid-19, the government recalibrates its vaccination strategy in the hope of inoculating India's 900 million adult population by December 31. How realistic is this target? - Issue Date: Jun 21, 2021
Monoclonal antibody drug production in India at reasonable price could be a game changer for the country in its fight against COVID-19, said Dr Arvinder S Soi
New Delhi [India], May 30 (ANI): Monoclonal antibody drug production in India at reasonable price could be a "game changer" for the country in its fight against COVID-19, said Dr Arvinder S Soin, Chairman, Institute of Liver Transplant and Regenerative Medicine at Medanta Hospital on Sunday.